Purchase Order 75N92020P00247

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $14,168.70 firm fixed-price purchase order to Molecular Devices LLC for a SPECTRAMAX MICROPLATE READER (AMBIS #2183390). Performance will take place in San Jose, California over a period of approximately four months concluding in late December 2023. As part of its mission to conduct and support medical research, the funding agency likely requires the...

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Molecular Devices LLC for a SpectraMax ID3 multi-mode microplate detection platform on September 21, 2020, with a ceiling value of $30,343.10. Performance occurs in San Jose, California. The order is firm fixed price with an ultimate completion date of October 20, 2020. The opportunity was posted as a pre-solicitation on September 3, 2020, with a due date of September 8, 2020.</p>

This firm-fixed-price purchase order for $41,597.00 was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a division of Danaher Corporation. The contract is for the delivery of a SpectraMax iD5 Standard Multimode Microplate Detection Platform, a specialized laboratory instrument used in life science research and drug discovery. Molecular Devices LLC is a manufacturer of high-performance...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Molecular Devices LLC on August 25, 2020, for a SpectraMax L luminescence microplate reader at $48,644.00 under firm fixed price. Place of performance is Bethesda, Maryland. The order was awarded without set-aside, following a solicitation posted July 24, 2020, with closing date August 4, 2020.</p>

The National Heart Lung and Blood Institute issued a delivery order to BMG Labtech, Inc. on June 22, 2021, with a ceiling value of $23,073.00 for an Omega Series microplate reader to support biological research at the NHLBI Knutson's Lab. The delivery order is placed under the General Services Administration's Multiple Award Schedule (MAS). Place of performance is Cary, NC 27513. The order is firm fixed price with an ultimate completion date of July 22, 2021. The microplate reader will be used...

<p>The Office of Logistics and Acquisition Operations issued a purchase order to Molecular Devices LLC on July 10, 2026, for a SpectraMax M3 Upgradable Microplate/Cuvette Reader with a ceiling value of $92,701.00 under firm fixed-price terms. Performance takes place in San Jose, California, with an ultimate completion date of August 10, 2026. No set-aside applies to this order.</p>

<p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for a microplate reader on September 22, 2020, with a ceiling value of $24,987.78 and a firm fixed price. Work is performed in San Jose, California, with an ultimate completion date of October 30, 2020. No small business set-aside applies to this order.</p>

<p>The Food and Drug Administration awarded a purchase order to Molecular Devices LLC for a SpectraMax ABS single-mode microplate reader valued at $15,794.00, with an award date of August 23, 2022 and ultimate completion date of September 22, 2022. Place of performance is San Jose, California. The order is firm fixed price with no set-aside applied.</p>

This federal contract award to Molecular Devices LLC, a division of Danaher Corporation, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for the purchase of a SpectraMax ID3 microplate reader. The $24,768.00 firm-fixed-price purchase order does not have a set-aside designation. Molecular Devices is a leading provider of high-performance bioanalytical measurement solutions for life science research,...

This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to Molecular Devices LLC, a division of Danaher Corporation, for a SERVICE AGREEMENT FOR SPECTRAMAX M3 MULTI-MODE MICROPLATE READER. The potential value of the contract is $14,122.00 and the completion date is June 24, 2025. Molecular Devices LLC is a major provider of high-performance bioanalytical measurement solutions for life sciences...